These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2841215)

  • 1. Effect of anti-insulin receptor antibodies on insulin-sensitive phosphodiesterase in rat fat cells.
    Suzuki T; Makino H; Kanatsuka A; Yoshida S
    Horm Metab Res; 1988 May; 20(5):257-60. PubMed ID: 2841215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of insulin action by fasting: a study using a phosphodiesterase activation system in rat fat cells.
    Osegawa M; Makino H; Kanatsuka A; Suzuki T; Hashimoto N; Yoshida S
    Horm Metab Res; 1985 Dec; 17(12):633-6. PubMed ID: 3002931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatomedin C on insulin-sensitive phosphodiesterase in rat fat cells.
    Kuribayashi N; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1988 Jul; 37(7):635-9. PubMed ID: 2838732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.
    Kahn CR; Baird K; Filier JS; Jarrett DB
    J Clin Invest; 1977 Nov; 60(5):1094-106. PubMed ID: 908753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of insulin-sensitive phosphodiesterase in fat cells (author's transl)].
    Makino H; Kawano T
    Horumon To Rinsho; 1981 Sep; 29(9):1073-6. PubMed ID: 6276055
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of changes in serum insulin in response to dexamethasone and adrenalectomy on insulin-sensitive phosphodiesterase in rat fat cells.
    Osegawa M; Makino H; Kanatsuka A; Suzuki T; Yoshida S
    Metabolism; 1984 Aug; 33(8):754-9. PubMed ID: 6087086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thyroidectomy, insulin, and phospholipids on cyclic AMP phosphodiesterase in rat adipocyte plasma membranes.
    Correze C; Thibout H
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(2):167-78. PubMed ID: 2987321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation, by insulin, of lipoprotein lipase and phosphodiesterase activities in rat adipose tissue.
    Desai K; Hollenberg CH
    Isr J Med Sci; 1975 Jun; 11(6):540-50. PubMed ID: 169209
    [No Abstract]   [Full Text] [Related]  

  • 11. Is phosphorylation involved in the action of insulin on cyclic AMP phosphodiesterase in fat cells?
    Tokumitsu Y; Kono T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():177-84. PubMed ID: 6326522
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin resistance of fat cells from spontaneously diabetic KK mice. Analysis of insulin-sensitive phosphodiesterase.
    Makino H; Kanatsuka A; Suzuki T; Kuribayashi S; Hashimoto N; Yoshida S; Nishimura M
    Diabetes; 1985 Sep; 34(9):844-9. PubMed ID: 2993083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells.
    Gammeltoft S; Vinten J; Gliemann J; Linde S
    Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antibody-mediated crosslinking of insulin on its bioactivity and receptor binding.
    Keilacker H; Knospe S; Ziegler M; Whittaker J
    Exp Clin Endocrinol; 1985 Feb; 85(1):38-46. PubMed ID: 3886410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An effect of insulin on cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in fat cells.
    Manganiello V; Vaughan M
    J Biol Chem; 1973 Oct; 248(20):7164-70. PubMed ID: 4355201
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of diet restriction on insulin-sensitive phosphodiesterase in rat fat cells.
    Suzuki T; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1987 Jan; 36(1):43-7. PubMed ID: 3025551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of insulin effects in fat cells may require energy for deactivation of glucose transport, but not deactivation of phosphodiesterase.
    Vega FV; Key RJ; Jordan JE; Kono T
    Arch Biochem Biophys; 1980 Aug; 203(1):167-73. PubMed ID: 6157364
    [No Abstract]   [Full Text] [Related]  

  • 18. On the role of 3',5'-cyclic amp phosphodiesterase in insulin action on rat liver and adipose tissue.
    Hepp D; Menahan A; Wieland O
    Horm Metab Res; 1969 Mar; 1(2):93-4. PubMed ID: 4334869
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the regulation of phosphodiesterase in human adipose tissue in vitro.
    Engfeldt P; Arner P; Ostman J
    J Clin Endocrinol Metab; 1983 Mar; 56(3):501-6. PubMed ID: 6296187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.
    Elias D; Rapoport M; Cohen IR; Shechter Y
    J Clin Invest; 1988 Jun; 81(6):1979-85. PubMed ID: 3290258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.